The noncoding RNA PCA3, which was initially characterized as Differential Display Code 3 (DD3), is prostate-tissue-specific and highly overexpressed in more than 95% of primary prostate cancers [1]. This evidence concerns the gene PCA3 and prostate carcinoma.